pioglitazone and glimepiride

Generic: pioglitazone and glimepiride

Labeler: prasco laboratories
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name pioglitazone and glimepiride
Generic Name pioglitazone and glimepiride
Labeler prasco laboratories
Dosage Form TABLET
Routes
ORAL
Active Ingredients

glimepiride 4 mg/1, pioglitazone hydrochloride 30 mg/1

Manufacturer
Prasco Laboratories

Identifiers & Regulatory

Product NDC 66993-822
Product ID 66993-822_370e643e-7cf8-4a0a-b6c4-78e96162c48f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA021925
Listing Expiration 2026-12-31
Marketing Start 2015-08-04

Pharmacologic Class

Established (EPC)
sulfonylurea [epc]
Chemical Structure
sulfonylurea compounds [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 66993822
Hyphenated Format 66993-822

Supplemental Identifiers

RxCUI
647237 647239
UPC
0366993822303 0366993821306
UNII
JQT35NPK6C 6KY687524K
NUI
N0000175608 M0020795

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pioglitazone and glimepiride (source: ndc)
Generic Name pioglitazone and glimepiride (source: ndc)
Application Number NDA021925 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 4 mg/1
  • 30 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (66993-822-30)
source: ndc

Packages (1)

66993-822-30 30 TABLET in 1 BOTTLE (66993-822-30)

Ingredients (2)

glimepiride (4 mg/1) pioglitazone hydrochloride (30 mg/1)

Linked Drug Pages (1)

pioglitazone and glimepiride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "370e643e-7cf8-4a0a-b6c4-78e96162c48f", "openfda": {"nui": ["N0000175608", "M0020795"], "upc": ["0366993822303", "0366993821306"], "unii": ["JQT35NPK6C", "6KY687524K"], "rxcui": ["647237", "647239"], "spl_set_id": ["ea385b3d-cb4c-4550-97b0-93a86533f6dc"], "pharm_class_cs": ["Sulfonylurea Compounds [CS]"], "pharm_class_epc": ["Sulfonylurea [EPC]"], "manufacturer_name": ["Prasco Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (66993-822-30)", "package_ndc": "66993-822-30", "marketing_start_date": "20150804"}], "brand_name": "pioglitazone and glimepiride", "product_id": "66993-822_370e643e-7cf8-4a0a-b6c4-78e96162c48f", "dosage_form": "TABLET", "pharm_class": ["Peroxisome Proliferator Receptor alpha Agonist [EPC]", "Peroxisome Proliferator Receptor gamma Agonist [EPC]", "Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]", "Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]", "Sulfonylurea Compounds [CS]", "Sulfonylurea [EPC]", "Thiazolidinedione [EPC]", "Thiazolidinediones [CS]"], "product_ndc": "66993-822", "generic_name": "pioglitazone and glimepiride", "labeler_name": "Prasco Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "pioglitazone and glimepiride", "active_ingredients": [{"name": "GLIMEPIRIDE", "strength": "4 mg/1"}, {"name": "PIOGLITAZONE HYDROCHLORIDE", "strength": "30 mg/1"}], "application_number": "NDA021925", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20150804", "listing_expiration_date": "20261231"}